发明名称 Stable compositions of peptide epoxy ketones
摘要 The invention relates to pharmaceutical compositions that provide improved solubility and stability for peptide epoxy ketones. More specifically, the invention relates to pharmaceutical compositions comprising the peptide epoxy ketone proteasome inhibitor carfilzomib.
申请公布号 US9636376(B2) 申请公布日期 2017.05.02
申请号 US201314023247 申请日期 2013.09.10
申请人 InnoPharma, Inc. 发明人 Hippalgaonkar Ketan;Soppimath Kumaresh;Pejaver Satish;Puri Navneet
分类号 A61K38/00;A61K38/07 主分类号 A61K38/00
代理机构 代理人 Konstas Kristina L.
主权项 1. A ready to use, multi-dose liquid pharmaceutical composition suitable for injection, comprising: (i) a liquid formulation comprising a non-volatile sugar acid, and carfilzomib or a pharmaceutically acceptable salt thereof; (ii) wherein the liquid formulation comprises a solvent system suitable for injection and including at least one of ethanol, propylene glycol, polyethylene glycol, and water; (iii) wherein the weight ratio of the non-volatile sugar acid to the carfilzomib or the pharmaceutically acceptable salt thereof ranges from 2:1 to 15:1; liquid formulation is present in a container in a quantity suitable for at least two independent and distinct administrations; and (iv) wherein the liquid formulation is formulated to maintain degradation of the carfilzomib or the pharmaceutically acceptable salt thereof at a level of less than 10% when the liquid formulation is stored over at least one month at 25 degrees Celsius and 60% relative humidity.
地址 New York NY US